Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Chouaib

Showing results (111-120 of 124) with videos related to

Pageof 13
Sort By:
European Cytokine Network|August 1, 1990
Functional and phenotypic modifications induced by IL-4, as single agent or in combination with IL-2, on PBMC preactivated in vivo by alpha-interferon + interleukin-2 therapyM Favrot, R Capdeville, V Combaret, et al.
Gene Therapy|April 1, 1997
Cloning of human IL-12 p40 and p35 DNA into the Semliki Forest virus vector: expression of IL-12 in human tumor cellsJ Zhang, C Asselin-Paturel, F Bex, et al.
Transplantation|May 15, 1997
Quantitative analysis of T helper 1, T helper 2, and inflammatory cytokine expression in patients after allogeneic bone marrow transplantation: relationship with the occurrence of acute graft-versus-host diseaseG Carayol, J H Bourhis, M Guillard, et al.
La Revue De Medecine Interne|February 23, 2010
[Gastrointestinal sarcoidosis]N Maàmouri, S Guellouz, F Ben Hariz, et al.
Oncogene|March 21, 2007
Distinctive role of integrin-mediated adhesion in TNF-induced PKB/Akt and NF-kappaB activation and endothelial cell survivalG Bieler, M Hasmim, Y Monnier, et al.
Gene Therapy|September 7, 1999
Transfer of the murine interleukin-12 gene in vivo by a Semliki Forest virus vector induces B16 tumor regression through inhibition of tumor blood vessel formation monitored by Doppler ultrasonographyC Asselin-Paturel, N Lassau, J M Guinebretière, et al.
British Journal of Cancer|March 6, 2014
Tumoral CD105 is a novel independent prognostic marker for prognosis in clear-cell renal cell carcinomaA Saroufim, Y Messai, M Hasmim, et al.
Oncogene|June 17, 2014
Targeting WNT1-inducible signaling pathway protein 2 alters human breast cancer cell susceptibility to specific lysis through regulation of KLF-4 and miR-7 expressionI Akalay, T Z Tan, P Kumar, et al.
European Journal of Immunology|December 18, 2001
Identification of HER-2/neu immunogenic epitopes presented by renal cell carcinoma and other human epithelial tumorsA Scardino, P Alves, D A Gross, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 2007
Efficacy of adjuvant chemotherapy according to Prion protein expression in patients with estrogen receptor-negative breast cancerF Meslin, R Conforti, C Mazouni, et al.
Pageof 13

Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
European Cytokine Network|August 1, 1990
Functional and phenotypic modifications induced by IL-4, as single agent or in combination with IL-2, on PBMC preactivated in vivo by alpha-interferon + interleukin-2 therapyM Favrot, R Capdeville, V Combaret, et al.
Gene Therapy|April 1, 1997
Cloning of human IL-12 p40 and p35 DNA into the Semliki Forest virus vector: expression of IL-12 in human tumor cellsJ Zhang, C Asselin-Paturel, F Bex, et al.
Transplantation|May 15, 1997
Quantitative analysis of T helper 1, T helper 2, and inflammatory cytokine expression in patients after allogeneic bone marrow transplantation: relationship with the occurrence of acute graft-versus-host diseaseG Carayol, J H Bourhis, M Guillard, et al.
La Revue De Medecine Interne|February 23, 2010
[Gastrointestinal sarcoidosis]N Maàmouri, S Guellouz, F Ben Hariz, et al.
Oncogene|March 21, 2007
Distinctive role of integrin-mediated adhesion in TNF-induced PKB/Akt and NF-kappaB activation and endothelial cell survivalG Bieler, M Hasmim, Y Monnier, et al.
Gene Therapy|September 7, 1999
Transfer of the murine interleukin-12 gene in vivo by a Semliki Forest virus vector induces B16 tumor regression through inhibition of tumor blood vessel formation monitored by Doppler ultrasonographyC Asselin-Paturel, N Lassau, J M Guinebretière, et al.
British Journal of Cancer|March 6, 2014
Tumoral CD105 is a novel independent prognostic marker for prognosis in clear-cell renal cell carcinomaA Saroufim, Y Messai, M Hasmim, et al.
Oncogene|June 17, 2014
Targeting WNT1-inducible signaling pathway protein 2 alters human breast cancer cell susceptibility to specific lysis through regulation of KLF-4 and miR-7 expressionI Akalay, T Z Tan, P Kumar, et al.
European Journal of Immunology|December 18, 2001
Identification of HER-2/neu immunogenic epitopes presented by renal cell carcinoma and other human epithelial tumorsA Scardino, P Alves, D A Gross, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 2007
Efficacy of adjuvant chemotherapy according to Prion protein expression in patients with estrogen receptor-negative breast cancerF Meslin, R Conforti, C Mazouni, et al.
Pageof 13